Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics
View Patent ↗Compounds complying with the general formula (I) in which R either represents a halogen atom or a phenyl group substituted by one or more groups chosen from halogen atoms and (C 1 –C 6 )alkyl, (C 1 –C 6 )alkoxy, nitro, amino, trifluoromethyl, cyano, hydroxy, acetyl or methylenedioxy groups, or represents a pyridinyl group, a thienyl group, an indolyl group, or a pyrimidinyl group optionally substituted by one or more (C 1 –C 6 )alkoxy groups, where, of the two carbon-carbon bonds represented by , one is single and the other may be single or double. Therapeutic application.
1. A compound in the form of an enantiomer or in the form of a mixture of enantiomers, having this formula (I)
in which R represents a (C 3 –C 6 )cycloalkyl group or a phenyl group substituted by one or more groups chosen from a halogen atom, or a (C 1 –C 6 )alkyl, (C 1 –C 6 )alkoxy, nitro, amino, C 1 –C 3 )dialkylamino, trifluoromethyl, trifluoromethoxy, cyano, hydroxy, acetyl or methylenedioxy group, or a piperidinyl, or morpholin-4-yl, or pyrrolidin-1-yl, or azetidin-1-yl, or azepin-1-yl, or pyridinyl, or quinolinyl, or thienyl, or pyrazinyl, or furyl, or benzofuryl, or benzothienyl, or indolyl, or pyrimidinyl, or isoxazolyl, or phenoxazinyl, or phenoxathienyl, or dibenzothienyl, or dibenzofuryl, or pyrrolyl, or naphthyl group, where each of these groups may optionally be substituted by one or more groups chosen from halogen atoms, (C 1 –C 6 )alkyl, (C 1 –C 6 )alkoxy, trifluoromethoxy, trifluoromethyl, nitro, cyano, hydroxy, amino, (C 1 –C 3 )dialkylamino or (C 3 –C 8 )cycloalkylamino groups, and where, of the two carbon-carbon bonds represented by , one is a single bond and the other is either a single bond or a double bond,
or a salt thereof.
2. The compound according to claim 1 wherein R represents a phenyl group substituted by one or more groups chosen from halogen atoms and (C 1 –C 6 )alkyl, (C 1 –C 6 )alkoxy, nitro, amino, trifluoromethyl, cyano, hydroxy, acetyl or methylenedioxy groups, or represents a pyridinyl group or a thienyl group or an indolyl group or a pyrimidinyl group optionally substituted by one or more (C 1 –C 6 )alkoxy groups.
3. A method for the treatment of a disorder selected from the group consisting of detrimental memory and attentional changes. Alzheimer's disease. Parkinson's disease, Tourette's syndrome and withdrawal from tobacco, which comprises administering to a patient in need of said treatment an effective amount of a compound according to claim 1 .
4. Pharmaceutical composition which comprises a compound according to claim 1 , together with an excipient.
5. A method for the treatment or of a disorder selected from the group consisting of detrimental memory and attentional changes, Alzheimer's disease, Parkinson's disease, Tourette's syndrome and withdrawal from tobacco, which comprises administering to a patient in need of said treatment an effective amount of a compound according to claim 2 .
6. Pharmaceutical composition which comprises a compound according to claim 2 , together with an excipient.
7. A compound selected from the group consisting of:
5-(6-bromo-pyridin-3-yl)-1-aza-bicyclo[3.2.1]oct-2ene; and
5-(6-bromo-pyridin-3-yl)-1-aza-bicyclo[3.2.1]oct-3-ene; or a salt thereof.
8. A pharmaceutical composition which comprises a compound according to claim 7 , or a pharmaceutically acceptable salt thereof together with an excipient.
9. A method for the treatment of a disorder selected from the group consisting of detrimental memory and attentional changes, Alzheimer's disease, Parkinson's disease, Tourette's syndrome and withdrawal from tobacco, which comprises administering to a patient in need of said treatment an effective amount of a compound according to claim 7 .